Array-based genomics in glioma research

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 28-38

  Idbaih, Ahmed ^a,b,c   Crinière, Emmanuelle ^a,b   Ligon, Keith L ^d,e   Delattre, Olivier ^f   Delattre, Jean Yves ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f INSTITUT CURIE   (France)

Author keywords

Array; Comparative genomic hybridization (CGH); Genomic; Glioma; Single nucleotide polymorphism (SNP)

Indexed keywords

ASTROCYTOMA; CANCER PATIENT; CANCER RESEARCH; COMPARATIVE GENOMIC HYBRIDIZATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; GENE LOCATION; GENOME ANALYSIS; GLIOBLASTOMA; GLIOMA; HUMAN; LABORATORY TEST; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; OLIGODENDROGLIA; OLIGODENDROGLIOMA; REVIEW;

ANIMALS; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; GENOMICS; GLIOBLASTOMA; GLIOMA; HUMANS; OLIGODENDROGLIOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 71549128098     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2009.00274.x     Document Type: Review

References (54)

1. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67 : 878 887.
2. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 104 : 20007 20012.
3. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI (2005) High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 65 : 4088 4096.
4. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90 : 1473 1479.
5. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79 : 1381 1393.
6. Cowell JK, Barnett GH, Nowak NJ (2004) Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa). J Neuropathol Exp Neurol 63 : 151 158.
7. Cowell JK, Matsui S, Wang YD, LaDuca J, Conroy J, McQuaid D, Nowak NJ (2004) Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 151 : 36 51.
8. Deshmukh H, Yeh TH, Yu J, Sharma MK, Perry A, Leonard JR et al (2008) High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene 27 : 4745 4751.
9. de Sthl TD, Hartmann C, de Bustos C, Piotrowski A, Benetkiewicz M, Mantripragada KK et al (2005) Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chromosomes Cancer 44 : 161 169.
10. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S et al (2001) Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60 : 248 262.
11. Griffin CA, Burger P, Morsberger L, Yonescu R, Swierczynski S, Weingart JD, Murphy KM (2006) Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol 65 : 988 994.
12. Hardenbol P, Banér J, Jain M, Nilsson M, Namsaraev EA, Karlin-Neumann GA et al (2003) Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat Biotechnol 21 : 673 678.
13. Hess KR, Broglio KR, Bondy ML (2004) Adult glioma incidence trends in the United States, 1977-2000. Cancer 101 : 2293 2299.
14. Hui AB, Lo KW, Yin XL, Poon WS, Ng HK (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 81 : 717 723.
15. Ichimura K, Mungall AJ, Fiegler H, Pearson DM, Dunham I, Carter NP, Collins VP (2006) Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 25 : 1261 1271.
16. Ichimura K, Vogazianou AP, Liu L, Pearson DM, Bäcklund LM, Plant K et al (2008) 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas. Oncogene 27 : 2097 2108.
17. Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P (2006) Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors. J Mol Diagn 8 : 433 443.
18. Idbaih A, Marie Y, Pierron G, Brennetot C, Hoang-Xuan K, Kujas M et al (2005) Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 58 : 483 487.
19. Idbaih A, Crinière E, Marie Y, Rousseau A, Mokhtari K, Kujas M et al (2008) Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas. Neuro Oncol 10 : 540 547.
20. Idbaih A, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros JM et al (2008) Chromosome 1p loss evaluation in anaplastic oligodendrogliomas. Neuropathology 28 : 440 443.
21. Idbaih A, Marie Y, Lucchesi C, Pierron G, Manié E, Raynal V et al (2008) BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer 122 : 1778 1786.
22. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M et al (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66 : 9852 9861.
23. Johnson NA, Hamoudi RA, Ichimura K, Liu L, Pearson DM, Collins VP, Du MQ (2006) Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells. Lab Invest 86 : 968 978.
24. Jones DT, Ichimura K, Liu L, Pearson DM, Plant K, Collins VP (2006) Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J Neuropathol Exp Neurol 65 : 1049 1058.
25. Jones DT, Kocialkowski S, Liu L, Pearson DM, Bäcklund LM, Ichimura K, Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68 : 8673 8677.
26. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M et al (2005) Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Genes Chromosomes Cancer 42 : 68 77.
27. Korshunov A, Sycheva R, Golanov A (2006) Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH). Acta Neuropathol 111 : 465 474.
28. Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A et al (2006) High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66 : 9428 9436.
29. Kros JM, Gorlia T, Kouwenhoven MC, Zheng PP, Collins VP, Figarella-Branger D et al (2007) Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome. J Neuropathol Exp Neurol 66 : 545 551.
30. Liu F, Park PJ, Lai W, Maher E, Chakravarti A, Durso L et al (2006) A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res 66 : 10815 10823.
31. Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, Cowell JK (2008) Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. Genes Chromosomes Cancer 47 : 221 237.
32. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 : 97 109.
33. Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A et al (2006) Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 66 : 11502 11513.
34. Mittler MA, Walters BC, Stopa EG (1996) Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 85 : 1091 1094.
35. Misra A, Pellarin M, Nigro J, Smirnov I, Moore D, Lamborn KR et al (2005) Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma. Clin Cancer Res 11 : 2907 2918.
36. Mohapatra G, Betensky RA, Miller ER, Carey B, Gaumont LD, Engler DA, Louis DN (2006) Glioma test array for use with formalin-fixed, paraffin-embedded tissue: array comparative genomic hybridization correlates with loss of heterozygosity and fluorescence in situ hybridization. J Mol Diagn 8 : 268 276.
37. Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C et al (2005) Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res 65 : 1678 1686.
38. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807 1812.
39. Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N et al (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118 : 1739 1749.
40. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9 : 157 173.
41. Prayson RA, Agamanolis DP, Cohen ML, Estes ML, Kleinschmidt-DeMasters BK, Abdul-Karim F et al (2000) Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 175 : 33 39.
42. Roerig P, Nessling M, Radlwimmer B, Joos S, Wrobel G, Schwaenen C et al (2005) Molecular classification of human gliomas using matrix-based comparative genomic hybridization. Int J Cancer 117 : 95 103.
43. Rossi MR, Gaile D, Laduca J, Matsui S, Conroy J, McQuaid D et al (2005) Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based comparative genomic hybridization. Genes Chromosomes Cancer 44 : 85 96.
44. Rossi MR, La Duca J, Matsui S, Nowak NJ, Hawthorn L, Cowell JK (2005) Novel amplicons on the short arm of chromosome 7 identified using high resolution array CGH contain over expressed genes in addition to EGFR in glioblastoma multiforme. Genes Chromosomes Cancer 44 : 392 404.
45. Ruano Y, Mollejo M, Ribalta T, Fiaño C, Camacho FI, Gómez E et al (2006) Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 5 : 39.
46. Schröck E, Thiel G, Lozanova T, du Manoir S, Meffert MC, Jauch A et al (1994) Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 144 : 1203 1218.
47. Seng TJ, Ichimura K, Liu L, Tingby O, Pearson DM, Collins VP (2005) Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Genes Chromosomes Cancer 43 : 181 193.
48. Shapiro JR, Yung WK, Shapiro WR (1981) Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res 41 : 2349 2359.
49. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18 : 636 645.
50. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J et al (2001) Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29 : 263 264.
51. The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 : 1061 1068.
52. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS et al (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163 : 1033 1043.
53. Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B et al (2007) Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas. Oncogene 26 : 1088 1097.
54. Wong KK, Tsang YT, Chang YM, Su J, Di Francesco AM, Meco D et al (2006) Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Cancer Res 66 : 11172 11178.